0001127602-24-004031.txt : 20240208
0001127602-24-004031.hdr.sgml : 20240208
20240208165100
ACCESSION NUMBER: 0001127602-24-004031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240207
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASPER MARC N
CENTRAL INDEX KEY: 0001216055
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08002
FILM NUMBER: 24609856
MAIL ADDRESS:
STREET 1: C/O THERMO FISHER SCIENTIFIC
STREET 2: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERMO FISHER SCIENTIFIC INC.
CENTRAL INDEX KEY: 0000097745
STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 042209186
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 7816221000
MAIL ADDRESS:
STREET 1: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: THERMO ELECTRON CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-02-07
0000097745
THERMO FISHER SCIENTIFIC INC.
TMO
0001216055
CASPER MARC N
168 THIRD AVENUE
WALTHAM
MA
02451
1
1
Chairman & CEO
1
Common Stock
2024-02-07
4
S
0
1160
552.72
D
57995
I
By Floral Park Associates, Inc.
Common Stock
2024-02-07
4
S
0
600
553.83
D
57395
I
By Floral Park Associates, Inc.
Common Stock
2024-02-07
4
S
0
3127
554.81
D
54268
I
By Floral Park Associates, Inc.
Common Stock
2024-02-07
4
S
0
3231
555.87
D
51037
I
By Floral Park Associates, Inc.
Common Stock
2024-02-07
4
S
0
900
556.82
D
50137
I
By Floral Park Associates, Inc.
Common Stock
2024-02-07
4
S
0
200
557.74
D
49937
I
By Floral Park Associates, Inc.
Common Stock
2024-02-07
4
S
0
400
561.03
D
49537
I
By Floral Park Associates, Inc.
Common Stock
2024-02-07
4
S
0
382
562.38
D
49155
I
By Floral Park Associates, Inc.
Common Stock
131174.767
D
Common Stock
11300
I
By Alison Casper 2020 Irrevocable Trust
Common Stock
5000
I
By MNC 2020 Irrevocable Trust
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, entered into on March 3, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.16 to $553.00, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.24 to $554.14, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.25 to $555.20, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.33 to $556.26, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.55 to $557.13, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.58 to $557.90, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $560.83 to $561.63, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $561.92 to $562.64, inclusive.
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
2024-02-08